Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Lung Cancer

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 60 articles:
HTML format



Single Articles


    January 2023
  1. LIANG X, Wu Q, Wang Y, Li S, et al
    MicroRNAs as early diagnostic biomarkers for nonsmall cell lung cancer (Review).
    Oncol Rep. 2023;49.
    PubMed     Abstract available


  2. HAN P, Zhou J, Xiang J, Liu Q, et al
    Research progress on the therapeutic effect and mechanism of metformin for lung cancer (Review).
    Oncol Rep. 2023;49.
    PubMed     Abstract available


    December 2022
  3. WANG M, Chen X, Fu G, Ge M, et al
    Glutathione peroxidase 2 overexpression promotes malignant progression and cisplatin resistance of KRASmutated lung cancer cells.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


  4. WANG Y, Li S, Weng L, Du H, et al
    LASS2 overexpression enhances early apoptosis of lung cancer cells through the caspasedependent pathway.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


  5. KAIRA K, Imai H, Kawasaki T, Hashimoto K, et al
    Potential of VEGFR2 expression as a predictive marker of PD1 blockade in patients with advanced NSCLC.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


  6. MIAO H, Hui H, Li H, Lin Y, et al
    PEDF inhibits nonsmall cell lung cancer proliferation by suppressing autophagy through downregulation of AMPKULK1 signaling.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


    November 2022
  7. SUMITOMO R, Huang CL, Ando H, Ishida T, et al
    Wnt2b and Wnt5a expression is highly associated with M2 TAMs in nonsmall cell lung cancer.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


    October 2022
  8. TAMARI S, Menju T, Toyazaki T, Miyamoto H, et al
    Nrf2/pFyn/ABCB1 axis accompanied by pFyn nuclear accumulation plays pivotal roles in vinorelbine resistance in nonsmall cell lung cancer.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


  9. HUANG Y, Wang X, Hu R, Pan G, et al
    SOX2 regulates paclitaxel resistance of A549 nonsmall cell lung cancer cells via promoting transcription of ClC3.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


    September 2022
  10. ZHANG G, Zheng H, Wang L
    miR4913p functions as a tumor suppressor in nonsmall cell lung cancer by targeting fibroblast growth factor 5.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


  11. ZHU H, Xu X, Zheng E, Ni J, et al
    LncRNA RP11805J14.5 functions as a ceRNA to regulate CCND2 by sponging miR34b3p and miR1395p in lung adenocarcinoma.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


    August 2022
  12. AN W, Zhang Y, Lai H, Zhang Y, et al
    Alpinia katsumadai Hayata induces growth inhibition and autophagyrelated apoptosis by regulating the AMPK and Akt/mTOR/p70S6K signaling pathways in cancer cells.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


  13. ZHANG J, Wang J, Wu J, Huang J, et al
    UBE2T regulates FANCI monoubiquitination to promote NSCLC progression by activating EMT.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


    July 2022
  14. LI H, Zhong R, He C, Tang C, et al
    Colonystimulating factor CSF2 mediates the phenotypic plasticity of smallcell lung cancer by regulating the pSTAT3/MYC pathway.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


  15. ZHOU F, Nie L, Feng D, Guo S, et al
    [Retracted] MicroRNA379 acts as a tumor suppressor in nonsmall cell lung cancer by targeting the IGF1Rmediated AKT and ERK pathways.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


  16. HUANG X, Jiang L, Lu S, Yuan M, et al
    Overexpression of ERCC6L correlates with poor prognosis and confers malignant phenotypes of lung adenocarcinoma.
    Oncol Rep. 2022;48.
    PubMed     Abstract available


    June 2022
  17. YAMAZAKI K, Hoshi M, Tezuka H, Morita N, et al
    Dallose enhances the efficacy of hydroxychloroquine against Lewis lung carcinoma cell growth by inducing autophagy.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


  18. ZHU F, Ren Z
    Icariin inhibits the malignant progression of lung cancer by affecting the PI3K/Akt pathway through the miR2055p/PTEN axis.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


    April 2022
  19. SUZUKI T, Sirimangkalakitti N, Baba A, Toyoshima-Nagasaki R, et al
    Characterization of the nucleotide excision repair pathway and evaluation of compounds for overcoming the cisplatin resistance of nonsmall cell lung cancer cell lines.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


  20. SUMITOMO R, Huang CL, Fujita M, Cho H, et al
    Differential expression of PDL1 and PDL2 is associated with the tumor microenvironment of TILs and M2 TAMs and tumor differentiation in nonsmall cell lung cancer.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


  21. CAO J, Yu U, Li L, Yuan X, et al
    circKL inhibits the growth and metastasis of kidney cancer by sponging miR1825p and upregulating FBXW7.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


    March 2022
  22. CHEN N, Zhou YS, Wang LC, Huang JB, et al
    Advances in metforminbased metabolic therapy for nonsmall cell lung cancer (Review).
    Oncol Rep. 2022;47.
    PubMed     Abstract available


  23. SHI Q, Shi QN, Xu JW, Wang HY, et al
    rs9390123 and rs9399451 influence the DNA repair capacity of lung cancer by regulating PEX3 and PHACTR2AS1 expression instead of PHACTR2.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


  24. WANG Y, Chen J, Huang Y, Yang S, et al
    Schisandrin B suppresses osteosarcoma lung metastasis in vivo by inhibiting the activation of the Wnt/betacatenin and PI3K/Akt signaling pathways.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


    February 2022
  25. LI Z, Li B, Niu L, Ge L, et al
    [Retracted] miR592 functions as a tumor suppressor in human nonsmall cell lung cancer by targeting SOX9.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


  26. HORIBE S, Ishikawa K, Nakada K, Wake M, et al
    Mitochondrial DNA mutations are involved in the acquisition of cisplatin resistance in human lung cancer A549 cells.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


  27. FUJII Y, Amatya VJ, Kushitani K, Suzuki R, et al
    Downregulation of lncRNA PVT1 inhibits proliferation and migration of mesothelioma cells by targeting FOXM1.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


    January 2022
  28. KEERATICHAMROEN S, Lirdprapamongkol K, Thongnest S, Boonsombat J, et al
    JAK2/STAT3mediated dosedependent cytostatic and cytotoxic effects of sesquiterpene lactones from Gymnanthemum extensum on A549 human lung carcinoma cells.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


  29. SONODA D, Kamizaki K, Matsuo Y, Aruga K, et al
    Characterization of morphological alterations in micropapillary adenocarcinoma of the lung using an established cell line.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


  30. FAN M, Arai M, Tawada A, Chiba T, et al
    Contrasting functions of the epithelialstromal interaction 1 gene, in human oral and lung squamous cell cancers.
    Oncol Rep. 2022;47.
    PubMed     Abstract available


    November 2021
  31. ZENG Y, Lv X, Du J
    Natural killer cellbased immunotherapy for lung cancer: Challenges and perspectives (Review).
    Oncol Rep. 2021;46.
    PubMed     Abstract available


    October 2021
  32. HUA X, Chu H, Wang C, Shi X, et al
    Targeting USP22 with miR305p to inhibit the hypoxiainduced expression of PDL1 in lung adenocarcinoma cells.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


    September 2021
  33. CHANG CY, Wu KL, Chang YY, Tsai PH, et al
    Amine oxidase, copper containing 3 exerts antimesenchymal transformation and enhances CD4(+) Tcell recruitment to prolong survival in lung cancer.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


  34. ZHANG Y, Yao H, Li Y, Yang L, et al
    Circular RNA TADA2A promotes proliferation and migration via modulating of miR638/KIAA0101 signal in nonsmall cell lung cancer.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


  35. JIN C, Shi L, Li K, Liu W, et al
    Mechanism of tumorderived extracellular vesicles in regulating renal cell carcinoma progression by the delivery of MALAT1.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


  36. WANG WJ, Wang J, Ouyang C, Chen C, et al
    Overview of serpin B9 and its roles in cancer (Review).
    Oncol Rep. 2021;46.
    PubMed     Abstract available


    August 2021
  37. KIM MK, Choi MJ, Lee HM, Choi HS, et al
    Heterogeneous nuclear ribonucleoprotein A2/B1 regulates the ERK and p53/HDM2 signaling pathways to promote the survival, proliferation and migration of nonsmall cell lung cancer cells.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


  38. LIN CC, Liao WT, Yang TY, Lu HJ, et al
    MicroRNA10b modulates cisplatin tolerance by targeting p53 directly in lung cancer cells.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


  39. ZHANG X, He Y, Jiang Y, Bao Y, et al
    TMEM229A suppresses nonsmall cell lung cancer progression via inactivating the ERK pathway.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


  40. LU R, Zhou Q, Ju L, Chen L, et al
    Upregulation of TRIP13 promotes the malignant progression of lung cancer via the EMT pathway.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


  41. MA J, Yan T, Bai Y, Ye M, et al
    TMEM100 negatively regulated by microRNA106b facilitates cellular apoptosis by suppressing survivin expression in NSCLC.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


  42. YANG L, Li N, Wang M, Zhang YH, et al
    Tumorigenic effect of TERT and its potential therapeutic target in NSCLC (Review).
    Oncol Rep. 2021;46.
    PubMed     Abstract available


  43. ZHANG Y, Liu S, Zhao T, Dang C, et al
    METTL3mediated m6A modification of Bcl2 mRNA promotes nonsmall cell lung cancer progression.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


  44. ZHU Y, Chen QY, Jordan A, Sun H, et al
    RUNX2/miR31/SATB2 pathway in nickelinduced BEAS2B cell transformation.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


    July 2021
  45. ZINNAH KMA, Park SY
    Sensitizing TRAILresistant A549 lung cancer cells and enhancing TRAILinduced apoptosis with the antidepressant amitriptyline.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


  46. ZENG T, Xu M, Zhang W, Gu X, et al
    Autophagy inhibition and microRNA199a5p upregulation in paclitaxelresistant A549/T lung cancer cells.
    Oncol Rep. 2021;46.
    PubMed     Abstract available


    June 2021
  47. BUACHAN P, Namsa-Aid M, Sung HK, Peng C, et al
    Inhibitory effects of terrein on lung cancer cell metastasis and angiogenesis.
    Oncol Rep. 2021;45.
    PubMed     Abstract available


  48. GAO L, Yang T, Zhang S, Liang Y, et al
    EHF enhances malignancy by modulating AKT and MAPK/ERK signaling in nonsmall cell lung cancer cells.
    Oncol Rep. 2021;45.
    PubMed     Abstract available


  49. LI S, Wang H, Ma R, Wang L, et al
    Schisandrin B inhibits epithelialmesenchymal transition and stemness of largecell lung cancer cells and tumorigenesis in xenografts via inhibiting the NFkappaB and p38 MAPK signaling pathways.
    Oncol Rep. 2021;45.
    PubMed     Abstract available


  50. WANG Z, Zhang X, Tian X, Yang Y, et al
    CREB stimulates GPX4 transcription to inhibit ferroptosis in lung adenocarcinoma.
    Oncol Rep. 2021;45.
    PubMed     Abstract available


  51. GLATZEL-PLUCINSKA N, Piotrowska A, Rzechonek A, Podhorska-Okolow M, et al
    SATB1 protein is associated with the epithelialmesenchymal transition process in nonsmall cell lung cancers.
    Oncol Rep. 2021;45.
    PubMed     Abstract available


    May 2021
  52. HE Q, Dong Y, Zhu Y, Ding Z, et al
    TMEM100 induces cell death in nonsmall cell lung cancer via the activation of autophagy and apoptosis.
    Oncol Rep. 2021;45.
    PubMed     Abstract available


  53. WANG H, Zhang P
    lncRNACASC15 promotes osteosarcoma proliferation and metastasis by regulating epithelialmesenchymal transition via the Wnt/betacatenin signaling pathway.
    Oncol Rep. 2021;45.
    PubMed     Abstract available


  54. ZHOU X, Sun T, Meng Y, Luo J, et al
    BET inhibitors combined with chemotherapy synergistically inhibit the growth of NSCLC cells.
    Oncol Rep. 2021;45.
    PubMed     Abstract available


  55. ZHOU H, Geng F, Chen Y, Du J, et al
    The mineral dust-induced gene, mdig, regulates angiogenesis and lymphangiogenesis in lung adenocarcinoma by modulating the expression of VEGF-A/C/D via EGFR and HIF-1alpha signaling.
    Oncol Rep. 2021;45.
    PubMed     Abstract available


  56. LIN S, Tian C, Li J, Liu B, et al
    Differential MUC22 expression by epigenetic alterations in human lung squamous cell carcinoma and adenocarcinoma.
    Oncol Rep. 2021;45.
    PubMed     Abstract available


    April 2021
  57. MURPHY A, Roy N, Sun H, Jin C, et al
    Induction of NUPR1 and AP1 contributes to the carcinogenic potential of nickel.
    Oncol Rep. 2021;45.
    PubMed     Abstract available


  58. HOSSIAN AKMN, Mackenzie GG, Mattheolabakis G
    Combination of miR143 and miR506 reduces lung and pancreatic cancer cell growth through the downregulation of cyclindependent kinases.
    Oncol Rep. 2021;45.
    PubMed     Abstract available


    January 2021
  59. ZHOU X, Liu B, Ning Q, Xia Z, et al
    Combination of Huanglian Jiedu Decoction and erlotinib delays growth and improves sensitivity of EGFRmutated NSCLC cells in vitro and in vivo via STAT3/Bcl2 signaling.
    Oncol Rep. 2021;45:217-229.
    PubMed     Abstract available


    October 2020
  60. XU L, Qu JL, Song N, Zhang LY, et al
    Biological and clinical significance of flap endonuclease1 in triplenegative breast cancer: Support of metastasis and a poor prognosis.
    Oncol Rep. 2020 Oct 16. doi: 10.3892/or.2020.7812.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: